Your browser doesn't support javascript.
loading
Timing of seasonal influenza epidemics for 25 countries in Africa during 2010-19: a retrospective analysis.
Igboh, Ledor S; Roguski, Katherine; Marcenac, Perrine; Emukule, Gideon O; Charles, Myrna D; Tempia, Stefano; Herring, Belinda; Vandemaele, Katelijn; Moen, Ann; Olsen, Sonja J; Wentworth, David E; Kondor, Rebecca; Mott, Josh A; Hirve, Siddhivinayak; Bresee, Joseph S; Mangtani, Punam; Nguipdop-Djomo, Patrick; Azziz-Baumgartner, Eduardo.
Afiliação
  • Igboh LS; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK; Immunization Systems Branch, Global Immunization D
  • Roguski K; National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Marcenac P; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Emukule GO; Centers for Disease Control and Prevention, Nairobi, Kenya.
  • Charles MD; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Tempia S; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Infectious Hazard Management, World Health Organization, Geneva, Switzerland.
  • Herring B; World Health Organization-Regional Office for Africa, Brazzaville, Congo.
  • Vandemaele K; Department of Infectious Hazard Management, World Health Organization, Geneva, Switzerland.
  • Moen A; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Olsen SJ; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Kondor R; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Mott JA; Department of Infectious Hazard Management, World Health Organization, Geneva, Switzerland.
  • Hirve S; Department of Infectious Hazard Management, World Health Organization, Geneva, Switzerland.
  • Bresee JS; The Task Force for Global Health, Decatur, GA, USA.
  • Mangtani P; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Nguipdop-Djomo P; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Azziz-Baumgartner E; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lancet Glob Health ; 11(5): e729-e739, 2023 05.
Article em En | MEDLINE | ID: mdl-37061311
ABSTRACT

BACKGROUND:

Using country-specific surveillance data to describe influenza epidemic activity could inform decisions on the timing of influenza vaccination. We analysed surveillance data from African countries to characterise the timing of seasonal influenza epidemics to inform national vaccination strategies.

METHODS:

We used publicly available sentinel data from African countries reporting to the WHO Global Influenza Surveillance and Response FluNet platform that had 3-10 years of data collected during 2010-19. We calculated a 3-week moving proportion of samples positive for influenza virus and assessed epidemic timing using an aggregate average method. The start and end of each epidemic were defined as the first week when the proportion of positive samples exceeded or went below the annual mean, respectively, for at least 3 consecutive weeks. We categorised countries into five epidemic patterns northern hemisphere-dominant, with epidemics occurring in October-March; southern hemisphere-dominant, with epidemics occurring in April-September; primarily northern hemisphere with some epidemic activity in southern hemisphere months; primarily southern hemisphere with some epidemic activity in northern hemisphere months; and year-round influenza transmission without a discernible northern hemisphere or southern hemisphere predominance (no clear pattern).

FINDINGS:

Of the 34 countries reporting data to FluNet, 25 had at least 3 years of data, representing 46% of the countries in Africa and 89% of Africa's population. Study countries reported RT-PCR respiratory virus results for a total of 503 609 specimens (median 12 971 [IQR 9607-20 960] per country-year), of which 74 001 (15%; median 2078 [IQR 1087-3008] per country-year) were positive for influenza viruses. 248 epidemics occurred across 236 country-years of data (median 10 [range 7-10] per country). Six (24%) countries had a northern hemisphere pattern (Algeria, Burkina Faso, Egypt, Morocco, Niger, and Tunisia). Eight (32%) had a primarily northern hemisphere pattern with some southern hemisphere epidemics (Cameroon, Ethiopia, Mali, Mozambique, Nigeria, Senegal, Tanzania, and Togo). Three (12%) had a primarily southern hemisphere pattern with some northern hemisphere epidemics (Ghana, Kenya, and Uganda). Three (12%) had a southern hemisphere pattern (Central African Republic, South Africa, and Zambia). Five (20%) had no clear pattern (Côte d'Ivoire, DR Congo, Madagascar, Mauritius, and Rwanda).

INTERPRETATION:

Most countries had identifiable influenza epidemic periods that could be used to inform authorities of non-seasonal and seasonal influenza activity, guide vaccine timing, and promote timely interventions.

FUNDING:

None. TRANSLATIONS For the Berber, Luganda, Xhosa, Chewa, Yoruba, Igbo, Hausa and Afan Oromo translations of the abstract see Supplementary Materials section.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Epidemias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Epidemias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2023 Tipo de documento: Article